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The association of several HSPs, including HSP27,5
HSP40 (HDJ-2),6 HSP47,7 HSP60,8,9 and HSP70,10,11
with vascular cells was identified either in the arterial wall
in situ or in vitro experiments. The level of expression of
both HSP40 messenger RNA and HSP70 messenger
RNA has been shown to be significantly increased in
carotid endarterectomy specimens in comparison with the
healthy arteries, with the level of HSP70 expression being
increased more than 2.5 times.6 With an immunohisto-
chemical approach, Berberian et al11 found a homoge-
neous distribution of HSP70 throughout the intima and
media in healthy aortas, and a strong increase in its
immunostaining intensity was observed in aortic athero-
sclerotic plaques. HSP70 was expressed most intensely
around areas of necrosis and lipid accumulation in the cen-
tral portion of atheroma.11
Immune responses are an important component of
atherosclerosis,1215 with recent study results indicating
that in atherogenesis both humoral and cellular autoim-
mune processes are directed toward HSPs.8-10 Chan 
et al10 have provided evidence of a correlation between
anti-HSP70 antibodies and different types of vascular dis-
ease, including atherosclerosis, which suggests that
HSP70 might be involved in their pathogenesis.
Dendritic cells (DCs) constitute a family of cells able
to induce primary immune responses.16-18 DCs are the
key cells in the initiation and regulation of immune
Hypoxia and oxidative stress contribute in atherogen-
esis1,2 and, like heat shock, increase the expression of
genes that encode stress, the so-called heat shock proteins
(HSPs).1,3,4 HSPs are responsible for the repair or degra-
dation of denatured proteins and, by the maintenance of
protein conformation, HSPs enhance the cell’s ability to
survive metabolic or oxidative stress.1,3,4 In the absence of
stress, many HSPs act as molecular chaperones that play a
vital role in healthy cellular processes that facilitate the
folding, assembly, and disassembly, and the translocation
of other proteins.3,4 The overexpression of HSPs is con-
sidered an important means of cell protection during
physiologic stress.3,4 The different families of HSPs are
classified by their molecular masses in kilodaltons.3,5
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Expression of heat shock protein–70 by dendritic
cells in the arterial intima and its potential
significance in atherogenesis
Yuri V. Bobryshev, PhD, and Reginald S. A. Lord, MD, Sydney, New South Wales, Australia
Objective: Overexpression of heat shock proteins (HSPs) is an important means of cell protection during physiologic
stress such as occurs during atherogenesis. Immune responses are early events in atherosclerosis, with recent studies
indicating that both humoral and cellular autoimmune processes in atherogenesis are directed toward HSPs. Dendritic
cells are the key cells in the initiation and regulation of immune responses. This study examined whether HSP70 is
overexpressed by dendritic cells in atherosclerotic lesions.
Methods: Twenty-six carotid artery and 16 aortic specimens obtained at endarterectomy and aortic reconstruction were
examined with immunohistochemical techniques. The nature of cells that overexpressed HSP70 was studied in consec-
utive sections that were double stained with antibodies to HSP70 and cell type–specific markers, including CD1a and
fascin (to identify dendritic cells), CD14 (monocytes), CD68 (macrophages), CD3 (T cells), CD15 (mast cells), von
Willibrand factor (endothelial cells), and α–smooth muscle actin (smooth muscle cells). Staining with HLA-DR and
CD1d was used to identify cells involved in antigen presentation.
Results: In advanced atherosclerotic lesions, several cell types, including monocytes, macrophages, dendritic cells, and
smooth muscle cells, overexpressed HSP70. In contrast, in early atherosclerotic lesions, only dendritic cells overex-
pressed HSP70. Dendritic cells that overexpressed HSP70 frequently contacted T cells and also expressed HLA-DR.
Furthermore, dendritic cells that clustered with T cells expressed CD1d, a unique molecule responsible for presenting
lipid antigens.
Conclusion: The results suggest that direct contacts between activated dendritic cells that overexpress HSP70 and T cells
might be responsible for T cell activation and might facilitate the presentation of lipid antigens to T cells directly within
the arterial wall. In early intimal lesions, HSP70 is overexpressed exclusively by dendritic cells, which suggests that den-
dritic cells might be involved in the early phases of atherogenesis. (J Vasc Surg 2002;35:368-75.)
responses.16-18 DCs are thought to arise from a common
CD34+ progenitor in the bone marrow from where they
migrate via the blood stream to settle in different periph-
eral tissues.16-18 After engulfing antigen, DCs migrate via
afferent lymph to activate T cells.16-18 DCs express high
levels of both class I and class II major histocompatibility
complex molecules and costimulatory molecules, which
explains their unique ability to activate naive T cells.16-18
In previous studies, we found that cells from the fam-
ily of DCs reside in the intima of large arteries and that
these vascular DCs are common in atherosclerotic
lesions.19-22 Vascular DCs exhibit ultrastructural character-
istics typical of other DCs19 and, like Langerhans cells and
interdigitating cells,18 vascular DCs express S-100 protein,
actin-bundling protein p55 (fascin), and CD1a, which are
markers for their immunohistochemical identification.20-22
Like other DCs,18 vascular DCs express HLA-DR21 and
display intercellular adhesion molecule-1 (ICAM-1) and
vascular adhesion molecule-1 (VCAM-1).21
In the nondiseased arterial wall, DCs are regularly
located along the subendothelial layer in numbers similar
to those of Langerhans cells in the skin, namely, 2% to
5%.19,21 In atherosclerotic lesions, the numbers of DCs
markedly increase, with more than 90% of DCs colocal-
ized with T cells in neovascularization areas associated
with inflammatory infiltrates.21 Inflammatory infiltrates in
atherosclerotic plaques contain activated T cells.12,15
Antigen-specific T cell activation depends on the interac-
tions of T cell receptors with antigens presented by MHC
molecules,12,15 and we earlier suggested that vascular DCs
might be the cells principally responsible for T cell activa-
tion in atherosclerosis.21 ICAM-1/leukocyte function–
associated antigen-1 and VCAM-1/very late antigen-4
interactions are critical in T cell activation,23 and the
observations that vascular DCs display HLA-DR, ICAM-
1, and VCAM-1 and locate amongst and contact T cells in
atherosclerotic lesions21 imply that DCs might activate T
cells directly in the injured arterial wall. Although some
DCs cluster with T cells within atherosclerotic lesions,
others seem to migrate to regional lymph nodes to activate
T cells.21
To be capable of activating T cells, DCs need to
undergo transition from the so-called DC immature forms
into the DC mature forms.16-18 Ultrastructural study
results showed that, in the healthy arterial wall, DCs reside
in their immature forms.19 The microenvironmental sig-
nals responsible for DC activation and maturation in
atherogenesis are unknown.
The results of several recent studies suggest that HSPs
are associated with DC function and possibly trigger DC
activation and maturation.24-29 Complexes of peptides
with different HSPs, including gp96, HSP90, and HSP70,
have been shown to be taken up by DCs and represented
by MHC class I molecules.29 The importance of HSPs in
the activation of DCs is of special interest in atherosclero-
sis research as evidence accumulates that both humoral
and cellular autoimmune processes directed toward HSPs
contribute in atherogenesis.10,13 This study was carried
JOURNAL OF VASCULAR SURGERY
Volume 35, Number 2 Bobryshev and Lord 369
out to determine whether HSP70 is associated with DCs
in atherosclerotic lesions.
METHODS
Tissue specimens. Arterial wall segments from 26
carotid arteries and 16 aortas were obtained from patients
whose ages ranged from 38 to 73 years. The carotid spec-
imens were obtained at endarterectomy, and the aortic
specimens (entire wall segments) were collected during
aortic reconstructions at St Vincent’s Hospital, Sydney,
Australia. The material was collected in accordance with
the principles outlined in the Declaration of Helsinki,30
and the study was approved by the institutional review
board of St Vincent’s Hospital, Sydney, Australia. Because
the specimens were relatively large (as much as 5 cm), it
was possible to find different atherosclerotic lesions,
including both early and advanced lesions, in the same
specimen. Some sites of the arterial wall not affected by
atherosclerosis were also identified. From every specimen,
small tissue pieces (about 1 mm3) were cut off and were
fixed in 2.5% glutaraldehyde in phosphate-buffered saline
solution (PBS; pH, 7.2). The arterial specimens then were
divided into two parts. One part from each specimen was
immediately embedded in OCT compound (Pelco
International, Redding, Calif ), rapidly frozen in liquid
nitrogen, and stored at –70°C until cryostat sectioning,
while the other part of the specimen was kept in ice-cold
PBS and used for the preparation of intimal sheets (so
called “Hautchen” specimens) for en face immunostaining
according to the technique described by Rekhter et al.31
Frozen arterial tissue blocks were cut at 5 to 7 µm
thickness sections. The sections stained with Mayer’s
hematoxylin and oil red O were examined to determine
the degrees of atherosclerotic alteration of the arterial
wall. Microscopic examination showed that every arter-
ial specimen contained sites displaying different stages of
atherosclerotic transformation, with 10 carotid artery
specimens containing small intimal sites without any
signs of atherosclerosis. All the aortic specimens con-
tained extensive areas of nonatherosclerotic arterial wall.
Intimal lesions containing some extracellular and intra-
cellular lipids (oil red O staining) and a few foam cells
intermingled with inflammatory cells irregularly scat-
tered in the superficial portion of the intima (mainly in
the swollen subendothelial layer) were classified as
“early” atherosclerotic lesions. These early atheroscle-
rotic lesions corresponded to the initial stage of forming
fatty streaks (type I and the initial stage of type II lesions
of the classification of Stary et al32,33). Thirty-six early
intimal lesions were identified. Noncomplicated athero-
sclerotic plaques with the lipid core still forming did not
contain fibrous caps and corresponded to intermediate
lesions (type III of the classification of Stary et al32,33).
“Advanced” atherosclerotic plaques contained lipid
(necrotic) cores, fibrous caps, and well-developed neo-
vascularization and were complicated by excessive calci-
fication and in some cases intramural hemorrhages.
These plaques mostly corresponded to Va, Vb, and VI
type atherosclerotic lesions of the classification of Stary
et al.33
Antibodies. Monoclonal antibody to HSP70 (B-6; sc-
7298) was purchased from Santa Cruz Biotechnology
(Santa Cruz, Calif). Expression of HSP70 was examined in
frozen sections in various concentrations (1:50; 1:100;
1:150; 1:200; 1:300) to distinguish between intimal cells
expressing and overexpressing HSP70. DCs were identi-
fied with both anti-CD1a (Dako, Carpinteria, Calif; NA/
34; 1:50) antibody and with antifascin antibody (Dako;
55K-2; 1:50). Macrophages were identified with anti-
CD68 antibody (Dako; EBM11; 1:50). T lymphocytes in
the arterial intima were identified with anti-CD3 (Dako;
CD3; 1:50). Smooth muscle cells were identified with anti-
body to α–smooth muscle actin (Dako; 1A4; 1:400).
Endothelial cells were identified with von Willebrand fac-
tor antibody (Dako; F8/86; 1:50). Mast cells were stained
with anti-CD15 (Dako; MMA; 1:50). Anti–HLA-DR
(Dako; CR/43; 1:50) and anti-CD1d (Research
Diagnostic, Inc, Flanders, NJ; NOR3.2; 1:25) were used
to identify cells involved in antigen presentation.
Single immunohistochemical staining. Single im-
munohistochemical staining was used to visualize the
expression of HSP70 and the distribution of different cell
types in the arterial specimens. An analysis was performed
with sets of consecutive parallel sections immunostained
with different antibodies. After the elimination of endoge-
nous peroxidase activity with 0.3% H2O2 for 5 minutes,
the sections were preincubated with nonimmune serum
and then tested with avidin-biotin complex (ABC) using
the ABC immunoperoxidase method34 as previously
described.20,21 In brief, after washing in tris-PBS (TPBS),
pH 7.6, the sections were incubated with the appropriate
secondary antibody. The sections then were washed in
TPBS for 5 minutes and treated with avidin-biotin com-
plex (Elite -ABC, Vector, Burlingame, Calif). After wash-
ing for 10 minutes in TPBS, a brown staining was
produced with the treatment of the sections with 3,3’-
diaminobenzidine as used previously. Alternatively, a red
staining was produced with treatment with the 3-amino,
9-ethylcarbazole (AEC) substrate kit or ABC substrate kit
as previously described.35 All the incubations were per-
formed at room temperature. For negative control, the
primary antibody was omitted or the sections were treated
with an immunoglobulin fraction of nonimmune serum as
a substitute for the primary antibody. None of the nega-
tive control sections showed positive immune staining.
Counterstaining was performed with Mayer’s hema-
toxylin, and sections were examined with an Olympus
microscope at 10 × 10 and 10 × 40 magnifications.
To distinguish between expression and overexpression
of HSP70 in the arterial specimens, we stained parallel
consecutive sections with HSP70 antibodies diluted in dif-
ferent concentrations. (The term “expression” is used in
this article in a wide sense. This term indicates the pres-
ence of HSP70 within cells and does not imply the syn-
thesis of this protein only.) Examination of nondiseased
portions of the arterial wall (in both aortic and carotid
JOURNAL OF VASCULAR SURGERY
370 Bobryshev and Lord February 2002
specimens) stained with the antibody diluted as 1:50
showed a low but specific and homogenous expression of
HSP70 in all intimal and medial cells, and no positive
immunostaining was observed in control sections. In con-
trast, a very strong intensity of immunostaining in some
areas of atherosclerotic plaques was obvious when the
antibody was used in the same concentration. When the
antibody was gradually diluted, no immunostaining was
observed in nondiseased portions of the arterial wall at a
1:300 dilution, and some cells in atherosclerotic lesions
still displayed a strong immunopositivity, which suggested
that these cells overexpressed HSP70. Therefore, we con-
cluded that a dilution of the antibody to 1:300 is suitable
to examine the distribution and the nature of cells that
overexpress HSP70 in the arterial wall. All single and dou-
ble immunostaining in this study were performed with the
antibody diluted to 1:300. 
Double immunohistochemical staining in sections.
For double immunostaining, combinations of the anti-
body to HSP70 with various cell type-specific antibodies
were used. This technique allows simultaneous staining for
detection of two different antigens in the same cell.
Double immunostaining procedures were performed as
previously described.35,36 In brief, after visualization of
the first antigen with the ABC substrate kit or with AEC
substrate kit, the tissue sections were washed several times
during 60 minutes with 0.1 mol/L glycine-hydrochloric
buffer (pH, 2.2) at 4°C. The sections were further incu-
bated overnight at 4°C with the secondary antibody. After
rinsing in TPBS, the sections were incubated with a
biotinylated antibody and then were incubated with alka-
line phosphatase-conjugated streptoavidin (Nichirei,
Chiba, Japan) or with avidin-biotin complex (Dako).
Alternatively, double immunostaining used a combination
of the peroxidase-antiperoxidase and alkaline phosphatase-
antialkaline phosphatase techniques as used previously.21
Negative controls were performed as in single immunos-
taining. Despite that double immunostaining clearly
shows the colocalization of two different antigens in the
same cells, the formation of immune reaction product
with the first primary antibody might preclude access of
the secondary primary antibody to the target antigen. To
avoid partial visualization of colocalized antigens, the
sequence of the application of the primary antibodies was
changed and, in addition, analysis of single staining in par-
allel consecutive sections was used.
En face double immunohistochemical staining in
intimal sheets. Intimal sheets were prepared according to
Rekhter et al.31 En face stained intimal sheets are trans-
parent for light microscopic examination and allow the
scanning of the intima at different depths.31 For en face
double immunostaining, acetone-fixed intimal sheets were
stained with the primary antibody with the same protocol
as described previously for the single immunostaining pro-
cedure with the AEC substrate kit in sections. After visu-
alization of the first antigen, the intimal sheets were
washed several times during 60 minutes with 0.1 mol/L
glycine-hydrochloric buffer (pH, 2.2) at 4°C. The intimal
sheets were further incubated overnight at 4°C with the
second primary antibody. After rinsing in PBS, the intimal
sheets were incubated with an appropriate biotinylated
antibody (Dako) for 12 hours at 4°C. After washing in
PBS, the intimal sheets were incubated at room tempera-
ture with alkaline phosphatase-conjugated streptoavidin
(Nichirei) for 30 minutes and the reaction was then visu-
alized with a fast blue substrate kit (Nichirei) as previously
described.35,36 Because the order of staining might affect
the results, the sequence of the primary antibody applica-
tion was reversed. Negative controls were performed as
described previously with the omission of the primary
antibodies. None of the negative control sections showed
positive immune staining.
Electron microscopic analysis. Electron microscopic
examination was performed to analyze the cell composition
of the arterial wall, with special attention to the structural
characteristics of DCs and their contacts with other intimal
cells. After fixation of arterial samples in 2.5% glutaralde-
hyde in PBS (pH, 7.2), specimens were postfixed in 1%
osmium tetroxide, dehydrated in graded ethanol and
propylene oxide, and then embedded in Araldite resin as
used previously.19 Serial ultrathin sections were cut on an
LKB-III ultratome (Stockholm, Sweden). Ultrathin sec-
tions were stained with uranyl acetate and lead citrate and
examined with the aid of a Hitachi H7000 electron micro-
scope (Hitachi, Japan) at an accelerating voltage of 100 kV. 
RESULTS
Distribution of heat shock protein–70 overexpres-
sion in atherosclerotic plaques. Cells that overexpressed
HSP70 were detected in all atherosclerotic lesions in both
carotid and aortic specimens, and no HSP70 overexpres-
sion was identified in all the nondiseased portions of the
arterial wall (the approach to distinguish between expres-
sion and overexpression of HSP70 in the arterial speci-
mens is described previously, in the Methods section). In
some segments of atherosclerotic arterial wall adjacent to
plaques, HSP70-positive cells were also present in the
media.
The patterns of HSP70 distribution in carotid artery
specimens were similar to those in aortic specimens. In dif-
ferent atherosclerotic lesions in the same vessel, numerical
differences in HSP70 overexpression were apparent be-
tween different layers of the intima and in different zones
of the same layers in all types of atherosclerotic lesions (III,
V, and VI types of atherosclerotic lesions32,33). Within
these atherosclerotic plaques, the areas containing HSP70
immunopositive cells bordered with the areas that were
free from HSP70 immunopositivity. The variations in the
extent of HSP70 expression were obviously not related to
the age of the patient or the duration of disease because
within the same arterial segments there were lesions with
different extents of HSP70 overexpression.
The most intensely immunostained cells were non-
foam oval or elongated cells, which, typically, were longi-
tudinally orientated along the arterial lumen (Fig 1A).
Some HSP70 immunopositive cells were represented by
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round or irregularly shaped cells containing a large num-
ber of lipid vacuoles (Fig 1A), and the intensity of HSP70
immunostaining in these foam cells was typically low. 
In advanced atheromatous plaques (V and VI types of
atherosclerotic lesions32,33), the external parts of the lipid
(necrotic) core were typically rich in HSP70 immunopos-
itive cells, but the fibrous caps showed a low proportion of
HSP70 overexpressing cells.
Nature of cells overexpressing heat shock pro-
tein–70 in atherosclerotic plaques. Comparison of serial
sections stained with cell type-specific antibodies showed
that most cells that overexpressed HSP70 were macro-
phages. Double immunostaining confirmed that HSP70
overexpressing cells also contained CD68 antigen (Fig
1B). Macrophages and some macrophage foam cells sur-
rounding the lipid core showed the strongest HSP70
immunopositivity. Analysis of serial sections and double
immunostaining also showed that a small proportion of
smooth muscle cells (α–smooth muscle actin+) displayed
HSP70 overexpression. Comparison of consecutive sec-
Fig 1. Heat shock protein–70 (HSP70) distribution in athero-
sclerotic plaques in carotid artery. A, Expression of HSP70 with
non-foam cells (large arrows) and foam cells (small arrows) in
superficial portion of atheromatous plaque. Lumen of artery is
marked with asterisk. ABC immunoperoxidase technique.
Visualization of HSP70 was produced with diaminobenzidine
(brown-colored product). Counterstaining with Mayer’s hema-
toxylin. B, Association of HSP70 (brown) with CD68 antigen
(rose) in shoulder area of atheromatous plaque (double immuno-
stained cells are shown with arrows). Combination of peroxidase-
antiperoxidase and alkaline phosphatase-antialkaline phosphatase
immunotechniques using AEC substrate and diaminobenzidine.
Counterstaining with Mayer’s hematoxylin. Magnification: ×400.
tions stained for CD3 and HSP70 immunopositivity indi-
cated that T cells (CD3+) did not overexpress HSP70.
When double immunostaining was applied, the colocaliza-
tion of HSP70 with CD3 antigen was not detected.
In this work, we were particularly interested to see
whether DCs overexpress HSP70 in atherosclerotic
lesions. Similar to the results of our previous studies,21,22
this study showed that although CD1a+ DCs were distrib-
uted irregularly throughout all the lesions, they were more
frequent near the neovasculature or within inflammatory
infiltrates. With careful visual scanning, sites where DCs
were located separately were found and the patterns of
their distribution were compared with the patterns of
HSP70 overexpression visualized in parallel consecutive
sections. This comparison suggested that the localization
of DCs corresponded to the areas that displayed an over-
expression of HSP70. Double immunostaining confirmed
colocalization of overexpression of HSP70 with CD1a
antigen (Fig 2). Practically all DCs located in cell-rich
areas and on the border of the necrotic core displayed
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HSP70 immunopositivity (Fig 2A). A large proportion of
DCs located in the deep portion of atherosclerotic intima
also showed HSP70 immunopositivity (Fig 2B). Analysis
of parallel consecutive sections showed that in these areas,
DCs expressed HLA-DR. HLA-DR was expressed by vari-
ety cell types in these areas. Analysis of parallel sections
also showed that, in cell-rich areas, DCs coexpressing both
CD1a and CD1d were colocalizing with T cells (Fig 3).
No other cell types expressed CD1d. Electron microscopic
examination confirmed the existence of direct contacts
between DC processes and lymphocytes and showed that
DCs contained hypertrophied cisterns of the tubulovesic-
ular system, which suggests their activation (Fig 4A).
Through their processes, DCs also contacted other cell
types (Fig 4B).
Distribution and nature of cells overexpressing
heat shock protein–70 in early intimal lesions. In early
intimal lesions (corresponding to type I and the initial
stage of type II of atherosclerotic lesions of the classifica-
tion of Stary et al32,33), only some cells located directly
under the endothelial monolayer displayed HSP70 over-
expression. Analysis of parallel consecutive sections stained
with a set of cell type-specific antibodies suggested that
this HSP70 overexpression is most likely to be associated
with CD1a+ DCs. However, this was not clearly apparent
Fig 2. Identification of heat shock protein–70 (HSP70) in den-
dritic cells in atherosclerotic plaque in carotid artery. A, Arrows
show CD1a+ dendritic cells (rose) located on border of necrotic
core in complicated atherosclerotic plaque and contained HSP70
(brown). Note intensive expression of HSP70 by foam cells sur-
rounding necrotic (lipid) core (shown with arrows). B, Arrows
show CD1a+ dendritic cells (rose) located in deep portion of ath-
erosclerotic intima. A,B, Combination of peroxidase-antiperoxi-
dase and alkaline phosphatase-antialkaline phosphatase
immunotechniques using AEC substrate and diaminobenzidine.
Counterstaining with Mayer’s hematoxylin. Magnification: ×400.
Fig 3. Expression of CD1d by dendritic cells in cell-rich areas in
atherosclerotic plaque in carotid artery. A and B represent con-
secutive sections that show coexpression of CD1a (rose; A) and
CD1d (rose; B) by dendritic cells (arrows). Immunoperoxidase
technique using AEC substrate; counterstaining with Mayer’s
hematoxylin. C, Colocalization of CD1d+ dendritic cells (rose;
arrows) with CD3+ T cells (brown). Combination of peroxidase-
antiperoxidase and alkaline phosphatase-antialkaline phosphatase
immunotechniques using AEC substrate and diaminobenzidine.
Magnification: ×400.
because it was practically impossible to identify the same
cells in parallel sections. In the subendothelial space, DCs
were intermingled with both macrophages and T cells,
and even though the patterns of HSP70 overexpression
were not similar with the patterns of distribution of both
macrophages and T cells, unambiguous identification of
the nature of overexpressing cells was difficult. For the
identification of the nature of cells overexpressing HSP70
in the subendothelial layer, en face staining of intimal
sheets was used. Double immunostaining showed that
only CD1a+ cells displayed HSP70 immunopositivity (Fig
5A). When microscopic fields of the intimal sheets were
examined at a magnification of ×400, DCs overexpressing
HSP70 were found to constitute as much as 80% of the
total number of DCs. Double immunostaining results
showed no association between HSP70 and macrophages
(CD68+) and between HSP70 and T cells (CD3+).
Electron microscopy showed the presence of cells with
characteristics typical of activated DCs. The distinctive fea-
ture of these cells was the presence of a tubulovesicular
system, which was most developed in the cellular processes
(Fig 5B). These DC processes were long and twisted, and
continuity between the cell body and the cellular processes
was established with the analysis of sets of ultrathin con-
secutive sections.
DISCUSSION
In an earlier immunohistochemical study, Berberian et
al11 found a low homogenous expression of HSP70
throughout the aortic intima and media and a strong
irregular HSP70 expression in aortic atherosclerotic
plaques. These study results agree with the findings of
Berberian at al11 in relation to aortic specimens, and we
also observed a similar pattern of HSP70 expression in
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carotid specimens. Berberian et al11 reported that strong
HSP70 expression was associated with macrophages and
macrophage foam cells. Our observations agree. 
We also found that in atherosclerotic plaques, DCs
overexpress HSP70, with practically all DCs located on
the border of the necrotic core and in cell-rich areas of
atherosclerotic lesions that display HSP70 overexpression.
In these areas, DCs coexpressed both CD1a and CD1d
and colocalized with T cells. CD1 proteins have been
recently recognized to be capable of binding and present-
ing exogenous and endogenous cellular lipids to T
cells.37,38 Lipid antigens are abundant in atherosclerotic
lesions, and our observations suggest that lipid antigen
presentation by CD1 proteins can contribute to the acti-
vation of T cells within plaques and thus initiate the cas-
cade of inflammatory processes, influencing the
progression of atherosclerosis.
Evidence of the involvement of immunologic and
inflammatory mechanisms in atherogenesis has been accu-
Fig 4. Contacts of dendritic cell processes (asterisks), containing
characteristic cisterns of tubulovesicular system, with lymphocyte
(star; A) and foam cell (B). B, “Lipid droplets” are marked by
stars. Electron microscopy. Magnification: ×14,000.
Fig 5. Association of heat shock protein–70 (HSP70) with acti-
vated dendritic cells in early intimal lesions of aorta. A,
Identification of HSP70 (blue) within CD1a+ dendritic cells
(rose) in intimal sheet using en face immunostaining technique.
CD1a antigen was visualized with AEC substrate, and visualiza-
tion of HSP70 was produced with Fast Blue substrate.
Magnification: ×400. B, Arrows show cross-section of dendritic
cell process, containing characteristic cisterns of tubulovesicular
system, located directly under endothelium. Lumen of aorta is
indicated with asterisk. Electron microscopy. Magnification:
×19,000.
A B
mulating during the past two decades.12-14 Recently, Wick
and coworkers13 proposed a new autoimmune hypothesis
for atherogenesis that postulated: 1, in the healthy arterial
intima, disseminated subendothelial accumulations of
immunocompetent cells and antigen-presenting DCs form
so-called vascular-associated lymphoid tissue, which
screens the microenvironment for potentially harmful
antigens; and 2, destabilization of vascular-associated lym-
phoid tissue by autoantigens is responsible for the initia-
tion of immune responses, leading to the development of
atherosclerotic lesions. DCs are central to this con-
cept.13,39 Understanding how DCs are activated could
lead to the development of a new approach for therapeu-
tic prophylaxis against atherosclerosis.
We earlier showed that atheroprone aortic areas contain
clusters of DCs19,40 and that some DCs are well-differenti-
ated in early intimal lesions.41 These observations were fur-
ther validated by the present electron microscopic
examination that showed that the tubulovesicular system in
DCs and their cellular processes are hypertrophied. The
peculiar network of tubules of the tubulovesicular system,
which is a unique feature of DCs, has been suggested to
facilitate the internalization and rapid intracellular transport
of antigens within the cytoplasm.18 The observation that
the tubulovesicular system is hypertrophied in DCs residing
in early intimal lesions implies that these DCs have the capa-
bility to engulf and process antigen.
No previous studies have investigated the expression
of HSP70 in early atherosclerotic lesions. This work shows
that overexpression of HSP70 occurs from the very early
stages of atherosclerotic alteration of the arterial intima
and that the intimal cells overexpressing HSP70 are DCs.
From these findings, we hypothesize that overexpression
of HSP70, and possibly some other HSPs, might be
important triggers for DC activation. The ability of HSPs
to chaperone peptides, including antigenic pep-
tides,24,26,27 to interact with antigen-presenting cells
through a receptor,28 to stimulate antigen-presenting cells
to secrete inflammatory cytokines,24-26 and to mediate
maturation of DCs29 makes them a unique starting point
for the generation of immune responses.
Our work shows that in both early and advanced ath-
erosclerotic lesions, DCs are associated with HSP70. This
work used immunohistochemical techniques that have
limitations in establishing the origin of HSP70 within
HSP70 overexpressing cells. HSP70 might be synthesized
directly by DCs. Alternatively, HSP70 might be abun-
dantly accumulated from the extracellular space or large
amounts of HSP70 within DCs might be a result of both
these events combined. The origin of HSP70 in DCs
requires further clarification. However, that HSP70 is
associated with DCs in early atherosclerotic lesions sug-
gests that vascular-associated DCs are activated from a
very early phase of atherogenesis.
CONCLUSION
In atherosclerotic plaques, various cell types, including
macrophages and DCs, overexpress HSP70. DCs that
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overexpress HSP70 were found frequently in contact with
T cells. DCs that cluster with T cells also express CD1d, a
unique molecule responsible for presenting lipid antigens.
Direct contacts between activated DCs that overexpress
HSP70 and T cells might be important in T cell activation
because they might facilitate the presentation of lipid anti-
gens to T cells directly within the arterial wall. In early
intimal lesions, only DCs overexpress HSP70, which sug-
gests that DCs are activated at a very early stage of athero-
genesis.
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